Crinetics Pharmaceuticals (CRNX) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | -347.04% |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 1,378.45% |
| 10 | Crinetics Pharmaceuticals | 8.72 Bn | 7.43 Bn | 10.53 Mn | 97.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.93% |
| Dec 31, 2025 | -33.81% |
| Sep 30, 2025 | -186.85% |
| Jun 30, 2025 | -454.54% |
| Mar 31, 2025 | -25,788.49% |
| Dec 31, 2024 | -80.50% |
| Sep 30, 2024 | 39.61% |
| Jun 30, 2024 | 87.96% |
| Mar 31, 2024 | 93.60% |
| Dec 31, 2023 | 297.63% |
| Sep 30, 2023 | 73.96% |
| Jun 30, 2023 | -32.58% |
| Mar 31, 2023 | -331.36% |
| Dec 31, 2022 | -53.96% |
| Sep 30, 2022 | -136.37% |
| Jun 30, 2022 | -128.68% |
| Mar 31, 2022 | 37.45% |
| Dec 31, 2021 | -41.75% |
| Sep 30, 2021 | 29.88% |
| Jun 30, 2021 | -12.21% |